Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
靶向卵巢癌中的受体酪氨酸激酶:基因组失调、抑制剂的临床评价及联合治疗的潜力
期刊:Molecular Therapy-Oncolytics
影响因子:5.3
doi:10.1016/j.omto.2023.02.006
Wei, Ying; Erfani, Sonia; Schweer, David; de Gouvea, Rafael; Qadir, Javeria; Shi, Junfeng; Cheng, Kai; Wu, Dabao; Craven, Rolf; Wu, Yadi; Olivier, Thibault; Baldwin, Lauren A; Zhou, Binhua; Zhou, Ying; Zhao, Weidong; Yang, Burton B; Ueland, Frederick R; Yang, Xiuwei H